Holistic approach towards health and wellness Core competencies of Active Pharmaceuticals Ingredient through specialized business verticals.
A global leader in Bulk Drug APIs production with USFDA approved facilities.
A global leader in Bulk Drug APIs production with USFDA approved facilities.
A global leader in Bulk Drug APIs production with USFDA approved facilities.
A Complete range of self care products ranging from BP Monitors To Glucose Monitors.
A Complete range of self care products ranging from BP Monitors To Glucose Monitors.
A huge range of 400+ products available over the counter with flagships like Burnol
A huge range of 400+ products available over the counter with flagships like Burnol
With standardized modern facilities to provide a wide range of products for various therapies.
With a standardized modern facilities to provide a wide range of products for various therapies.
Committed towards quality and innovative products
In Morepen's three-and-a-half decade journey, we have always aspired to be an organisation with tangible, visible differences where every individual action is inspired by a deep, humbling desire to make a difference to the lives we touch. Our state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company's extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards. With a strong global presence, Morepen exports to over 75 countries with certifications from all major regulatory authorities like USFDA, WHO GMP, EU GMP. Our domestic products under the brand name, Dr. Morepen and Gubb world have a huge range of healthcare, grooming and OTC products trusted by over 100 million consumers.
Know More >>
Morepen also holds process patents for Montelukast Sodium Amorphous in Global, USA, Canada, Europe & India.
ISO 9001:2005 and ISO 13485:2016 certification for medical devices manufacturing facility at Baddi (H.P.). This enables us as one of the largest manufacturers in point-of-care diagnostic devices in India.
Awarded Certificate of Appreciation by Pharmaceuticals export promotion council (Pharmexcil), setup by Ministry of Commerce & Industry, Government of India for 3 consecutive years.
Net Profit before tax up by 97% to Rs. 38.53 crores.
API Business growth up by 17%, contributing to 52.1% standalone revenue .
172% increase in gross revenue form OTC products with over 259% increase in OTC and Grooming range business.
110% increase in online sales, with 24% CAGR in Dr. Morepen Brand Portfolio.
R&D Spend up by 112% with around 246 resources focused on $40B Generic Market.
Highest ever growth of 189% in revenue from medical devices with oximeters, BP Monitors and Gluco Monitors as key growth drivers.
Net Profit before tax up by 97% to Rs. 38.53 crores.
110% increase in online sales, with 24% CAGR in Dr. Morepen Brand Portfolio.
API Business growth up by 17%, contributing to 52.1% standalone revenue .
R&D Spend up by 112% with around 246 resources focused on $40B Generic Market.
172% increase in gross revenue form OTC products with over 259% increase in OTC and Grooming range business.
Highest ever growth of 189% in revenue from medical devices with oximeters, BP Monitors and Gluco Monitors as key growth drivers.
Burnol a name every household trusts for quick healing of burns and cuts for more than two decades. An effective antiseptic and antibacterial topical ointment.
Lemolate Gold is a trusted medicine for cold, cough, and flu that provides superior relief without leaving you drowsy.
An alcohol-based sanitizer that thoroughly disinfects your hands while keeping them soft and leaves your hands smelling great!
28thJul
2021
Morepen Labs Profit Rises 57% To ₹ 30 Crore In June Quarter, Stock Gains 3%
27thJul
2021
06thJul
2021
12thMay
2021
125% jump in a month, 360% in a year; safety rush turns this laggard a multibagger
Investor Presentation for Q1 FY22
